adf5646
-
Upload
kishan-grama-narasimhaprasad -
Category
Documents
-
view
227 -
download
0
Transcript of adf5646
-
8/6/2019 adf5646
1/24
1
Indian Ayurvedic System of Medicine: Scope forNew Drug Design and Discovery
Dr. Narshinha P. Argade
Division of Organic ChemistryNational Chemical Laboratory, Pune 411 008
INDIA
-
8/6/2019 adf5646
2/24
2Saraswati: Godess of KnowledgeMother of Vedas
Dhanwantari: Physician of GodsFather and Promulgator of Ayurveda
Guru-Shishya Tradition
INDIA / CHINA
-
8/6/2019 adf5646
3/24
3
World of Ayurveda: Rich Repository of Original Knowledge Charak Samhita Sushruta Samhita Madhava Nidana Astanga Haridaya
Indian area: 2.4% of the world with range of geoclimatic conditions Indian biodiversity: 8.1% of the world Indian Plant Species: 45000 (3000 used in Ayurveda) Indian Ayurvedic formulations: 35000 + Bhasmas Indian Registered Ayurvedic Practitioners: 6,00,000
http://images.google.co.in/imgres?imgurl=http://lh6.ggpht.com/_PDHWS6OSLfU/R3s8yg1ApPI/AAAAAAAAEYY/Dt95rvEk1fQ/P1010218.JPG&imgrefurl=http://picasaweb.google.com/lh/photo/Y_AhgWh_zJ68TeVqAv_v3w&h=1712&w=2288&sz=175&hl=en&start=9&um=1&tbnid=fV3PCl1m-bAXkM:&tbnh=107&tbnw=143&prev=/images%3Fq%3DPicture%2Bof%2Bdense%2BIndian%2Bforest%26um%3D1%26hl%3Den%26sa%3DXhttp://images.google.co.in/imgres?imgurl=http://www.northindiatours.indianconsultancy.com/gifs/north-india-forest.jpg&imgrefurl=http://www.northindiatours.indianconsultancy.com/&h=239&w=261&sz=17&hl=en&start=15&um=1&tbnid=qW7SdaljSwWYfM:&tbnh=103&tbnw=112&prev=/images%3Fq%3DPicture%2Bof%2Bdense%2BIndian%2Bforest%26um%3D1%26hl%3Den%26sa%3DX -
8/6/2019 adf5646
4/24
4
Development of Ayurvedic FormulationsObservationHypothesis formulationTesting by experimentsInduction derived general principleApplication of general principle
http://www.organicindia.com/images/ayurveda.jpg -
8/6/2019 adf5646
5/24
5
Disease Plant species Common nameMultiresistant Tuberculosis Cyperus rotundus Motha
Obesity & heart diseases Commiphora mukul Guggulu
Cancer Rubia cordifolia Manjistha
Diabetes Petrocarpus marsupium Vijaysar
Asthma Adhatoda vasica Adhulsa
Hepatitis Peganum nigellastrum Syrian rue
Diseases and Ayurvedic Medicines
-
8/6/2019 adf5646
6/24
6
Comparison of Ayurvedic System of Medicine with AllopathyAyurvedic System Allopathic System
Experiential Experimental
Reductionistic
Health oriented Disease oriented
Diet oriented Drug and surgery orientedGreen pharmacy Red pharmacy
Pro-nature Anti-nature
Client oriented Profession orientedActive on all humans Active on 30% humans
No side effects Side effects
Mode of action unknown Mode of action known ?
Slow effects Fast effects
Holistic
Philophical Physical
-
8/6/2019 adf5646
7/24
7
First Institute of AyurvedicEducation: Gurukul Kangdi
Ayurvedic Colleges in India: 210
BAMS: 8000
MAMS: 600 I Desire that the Diseases andMiseries of all Living Beings areResolved
Shri Zandu Bhattji
-
8/6/2019 adf5646
8/24
8
Natural Products Derived Drugs 1998-2004
-
8/6/2019 adf5646
9/24
9
New Drug Discovery @ NCL
N
N
O
OH
NH
NN
O
O
OH
O
O
O
O
O
O
O
HO
HO
H
H
H
H
AssayDevelopment
High-ThroughputScreening
Separation
Parallel
Synthesis
Evaporation
Extraction
Hits & Leads
NewDrugs
Natural Products
Synthetic Products
-
8/6/2019 adf5646
10/24
10
Dr. G. V. Satyavati
1966-Guggulu Girl
O
O
Z-Guggulsterone
(Cholesterol Lowering Agent)
G. V. Satyavati et al. Ind. J. Med. Res. 1988, 87, 327.
Commiphora mukul
-
8/6/2019 adf5646
11/24
11
A Natural Product That Lowers Cholesterol As anAntagonist Ligand for FXRNancy L. Urizar, Amy B. Liverman, DNette T. Dodds, Frank Valentin Silva,Peter Ordentlich, Yingzhuo Yan, Frank J. Gonzalez, Richard A. Heyman, David
J. Mangelsdorf, David D. Moore*
The gum resin of Commiphora mukul (guggulu in Sanskrit)has been used in Ayurvedic medicine since at least 600 BC totreat a wide variety of ailments, including obesity and lipiddisorders.
Science 2002,296, 1703.
-
8/6/2019 adf5646
12/24
12
(-)-Vasicine, (-)-Vasicinone and Isovasicinone
N
N
O
OH(-)-Vasicinone
N
N
OH(-)-Vasicine
Iso la t ion: A d h a t o d a v a s i c a
Act i v it y : Used in The Indian Ayurvedic Sys tem o f
Medic ine as a remedy fo r cough, co ld and
bronch i t i s
N
N
O OH
Isovasicinone
-
8/6/2019 adf5646
13/24
13
N
N
O
N
N
O
OH
Davis reagent
-78 oC
39% (71% ee)
Earlier Approaches towards Vasicinone
Eguchi et al. J. Org. Chem. 1996, 61, 7316.
N
N
O
OHN
N
O
OAc
Amano PS, VA
THF
45% (100% ee)
Kamal et al. J. Org. Chem. 2001, 66, 997.
-
8/6/2019 adf5646
14/24
14
NCL-Synthesis of (-)-Vasicinone
NH2
NH2
O
O
O
OOAc
+
CONH2
NH
OHOO
OAc
CONH2
NH
OO
OMe
OAc
CONH2
NH
OOH
OH
N
NHOH
O
OH
N
N
O
OH
(98%) (98%)
(92%)
(90%)
7 6
2 3 45
(-)-Vasicinone (1)
Ether CH2N2
(a) LAH(b) H2O
DEAD,TPP
S. B. Mhaske and N. P. Argade J. Org. Chem. 2001, 66, 9038.
-
8/6/2019 adf5646
15/24
15
Synthesis of (-)-Vasicine - in Progress
TFA
NH2
NHBocO
O
OOAc
+NH
OHOO
OAc
NHBoc
NH
OO
OMe
OAc
NHBoc
NH
OOH
OH
NHBoc
N
NHOH
OH
N
N
OH
(95%) (87%)
7 6
2 3 4 5
(-)-Vasicine (1)
Ether CH2N2
LAH, THF(73%)
?X
-
8/6/2019 adf5646
16/24
-
8/6/2019 adf5646
17/24
17
Batey et al. Org. Lett. 2004, 6, 4913.
Yao et al.J. Org. Chem. 2007, 72, 6270.
N
N
H
O
O
N
O
N
N
Aniline, Dy(OTf)3
(51%)
N
N
O
O
NH
Ph3PO, Tf2O
(99%)
1
2
Earlier Approaches towards Luotonin A
-
8/6/2019 adf5646
18/24
18
An Efficient Biogenetic Total Synthesis of Luotonin F
NH2
O
NH2 +
1
O
O
O
N
NH
O
OH
N
N
O OH
Pegamine
N
N
NH
O
2
(93%)
(96%)(62%)
Deoxoluotonin F (8)
NH
CONH2O COOH
NH
CONH2O
COOMe
43
Et2O
(98%) (98%)
CH2N2
(i) LAH/THF(ii) H2O
PCC
(64%)
Isovasicinone (7)
o-Amino-benzaldehyde,KOH CrO3/H5IO6
[5]NH
CONH2O
OH
N
NH
O
CHO
[6]
N
N
NH
O
O
Luotonin F
Practical Synthesis of Luotonin A and Luotonin B & E via
-
8/6/2019 adf5646
19/24
19
Practical Synthesis of Luotonin A and Luotonin B & E via
Novelortho-Directed Lithiation
NH2
NH2
O
NCl
ON
NH
N
O
NH
O
N
CONH2
N
N
N
O
N
NH
N
O OH
N
N
N
O
N
N
N
O OMe
N
N
N
O OH
N
NLi
N
OCHO
+
Luotonin A (1a)
Luotonin B (1b)Luotonin E (1c)
i ii
iiia
iv
iiic
iiib
v
vi
2 3 4 5
[6]7
[8]
LiLi
(96%) (98%)
(86%)
(81%)
(95%)
(61%)
(82%)
8
3`
8`
Reagents,condition and Yields: (i) TEA (2 eq.), THF, rt, 3 h (96%); (ii) 5% aq. KOH, EtOH, reflux, 5 min. (98%); (iiia) Mesityllithium (2.2 eq.), 78 oC, 1 h to 20 oC (gradually), (iiib) THF solution of HCHO (5 eq.), 30 oC, 20 min., saturated aq. solution ofNH4Cl (86%), (iiic) DMF (5 eq.),
20
o
C, 30 min., saturated aq. solution of NH4Cl (81%); (iv) PPh3 (1.3 eq.), DEAD (1.2 eq.), THF,rt, 1 h (95%); (v) PCC (1.2 eq.), powdered 4 molecular sieves, DCM, rt, 1 h (61%); (vi)p-TSA (5 eq.), MeOH, reflux, 3 h (82%).
S. B. Mhaske and N. P. ArgadeJ. Org. Chem. 2004, 69, 4563.
-
8/6/2019 adf5646
20/24
20
NH
NH2MeO
O
O
O
CH3
+
MeON
NH
CH3
HOOC
Luotonin C (1)
N
NMeO
O
CH3
MeON
CH3
N
O
NHNH
MeOO
CH3
HOOC
2 3 4
5 6
Synthesis of Luotonins C, in Progress
P. B. Wakchaure and N. P. Argade (Unpublished results).
-
8/6/2019 adf5646
21/24
21
Indian AyurvedicSystem of Medicine Chemist Doctor
Safe but slow Fast and moresafe
A k l d t
http://images.google.co.in/imgres?imgurl=http://www.saunalahti.fi/~marian1/gourmet/pic/s_sand.jpg&imgrefurl=http://www.saunalahti.fi/~marian1/gourmet/i_sugars.htm&h=170&w=170&sz=10&hl=en&start=245&um=1&tbnid=RvF8UWL2dGMtNM:&tbnh=99&tbnw=99&prev=/images%3Fq%3Dphoto%2Bof%2Bcoloured%2Bcrystalline%2Bcompound%26start%3D240%26ndsp%3D20%26um%3D1%26hl%3Den%26sa%3DN -
8/6/2019 adf5646
22/24
22
Acknowledgements
Aquapharm Ltd., PuneRecon Ltd., BangaloreGodrej Agrovet, MumbaiParke-Davis, USAYamanuchi, JapanNikem, ItalyDST, New DelhiCSIR, New DelhiICS-UNIDO, ItalyDr. G. P. Pandey, HeadDOC, NCL, PuneDr. S. Sivaram, DirectorNCL, Pune, India
Dr. S. B. DesaiDr. A. M. DeshpandeDr. S. MangaleswaranDr. S. B. MhaskeDr. Anirban KarDr. S. EaswarDr. M. MondalDr. Merajuddin BaagDr. Sanjib GogoiMr. Kishan Haval (SRF)Mr. Umesh Kshirsagar (SRF)Mr. Ramesh Patel (SRF)Mr. Prasad Wakchaure (SRF)Mr. Mandeep Singh (JRF)Mr. Prashant Deore (JRF)
Th f thi l b t i t d k l d
-
8/6/2019 adf5646
23/24
23
www.ncl-india.org
The purpose of this laboratory is to advance knowledgeand apply chemical science for the good of the people
National Chemical Laboratory, Pune, India
-
8/6/2019 adf5646
24/24